Heron Therapeutics Inc (HRTX)

07:00 AM

California public company relocates to North Carolina - The Business Journals

07:00 AM

Dec 23, 2024

Heron Therapeutics Relocates Headquarters to North Carolina - TipRanks

Dec 23, 2024

Dec 23, 2024

Heron Therapeutics, Inc. Announces Corporate Headquarters Relocation to Cary, North Carolina - Marketscreener.com

Dec 23, 2024

Dec 19, 2024

Heron Therapeutics (NASDAQ:HRTX) Rating Lowered to “Hold” at StockNews.com - Defense World

Dec 19, 2024

Dec 19, 2024

Heron Therapeutics (NASDAQ:HRTX) Cut to "Hold" at StockNews.com - MarketBeat

Dec 19, 2024

Dec 18, 2024

Fmr LLC Has $859,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Dec 18, 2024

Dec 16, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by Verition Fund Management LLC - Defense World

Dec 16, 2024

Dec 16, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Lowered by Charles Schwab Investment Management Inc. - Defense World

Dec 16, 2024

Dec 12, 2024

U.S. District Court Upholds Validity of CINVANTI® Patents - The Eastern Progress Online

Dec 12, 2024

Dec 11, 2024

Exploring Three High Growth Tech Stocks In The United States - Yahoo Finance

Dec 11, 2024

Dec 11, 2024

Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer - The Eastern Progress Online

Dec 11, 2024

Dec 11, 2024

StockNews.com Upgrades Heron Therapeutics (NASDAQ:HRTX) to "Buy" - MarketBeat

Dec 11, 2024

Dec 11, 2024

Heron Therapeutics (NASDAQ:HRTX) Rating Increased to Buy at StockNews.com - Defense World

Dec 11, 2024

Dec 08, 2024

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance - Kilgore News Herald

Dec 08, 2024

Dec 07, 2024

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors - The Eastern Progress Online

Dec 07, 2024

Dec 05, 2024

StockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Hold - Defense World

Dec 05, 2024

Dec 04, 2024

Relief For Heron Therapeutics After The Court Win On Cinvanti - Seeking Alpha

Dec 04, 2024

Dec 04, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Dec 04, 2024

Dec 04, 2024

Heron Therapeutics wins patent case for CINVANTI drug - Investing.com

Dec 04, 2024

Dec 04, 2024

Heron Therapeutics wins patent case for CINVANTI drug By Investing.com - Investing.com Canada

Dec 04, 2024

Dec 03, 2024

Heron Therapeutics Shares Soar 91% on Patent Dispute Win - MarketWatch

Dec 03, 2024

Dec 03, 2024

Heron Therapeutics Wins Major Patent Battle Over CINVANTI, Blocks Generic Until 2035 - StockTitan

Dec 03, 2024

Nov 30, 2024

Heron Therapeutics: Approved Therapy With Blockbuster Potential But Meager Revenues (NASDAQ:HRTX) - Seeking Alpha

Nov 30, 2024

Nov 26, 2024

Biotech Finds Mid-Week Success Following Q4 Earnings Release - MSN

Nov 26, 2024

Nov 26, 2024

Principal Financial Group Inc. Has $204,000 Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Nov 26, 2024

Nov 24, 2024

Heron Therapeutics: Q3 Earnings Snapshot - Marketscreener.com

Nov 24, 2024

Nov 21, 2024

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to “Hold” - Defense World

Nov 21, 2024

Nov 21, 2024

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to "Hold" - MarketBeat

Nov 21, 2024

Nov 20, 2024

Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 20, 2024

Nov 20, 2024

Heron Therapeutics Q3 2024 Earnings Preview - MSN

Nov 20, 2024

Nov 19, 2024

Heron Therapeutics Inc (NASDAQ: HRTX) Declines -1.68%: This $177.95 million Stock Could Go Down -669.23% - Stocks Register

Nov 19, 2024

Nov 18, 2024

Short Interest in Heron Therapeutics, Inc. (NASDAQ:HRTX) Declines By 6.0% - MarketBeat

Nov 18, 2024

Nov 17, 2024

Northland Capmk Has Pessimistic View of HRTX Q4 Earnings - Defense World

Nov 17, 2024

Nov 15, 2024

Equities Analysts Set Expectations for HRTX Q4 Earnings - MarketBeat

Nov 15, 2024

Nov 15, 2024

Heron Therapeutics (NASDAQ:HRTX) Raised to Buy at StockNews.com - Defense World

Nov 15, 2024

Nov 14, 2024

Heron Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St

Nov 14, 2024

Nov 13, 2024

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Needham & Company LLC Has Lowered Expectations for Heron Therapeutics (NASDAQ:HRTX) Stock Price - MarketBeat

Nov 13, 2024

Nov 13, 2024

Why Investors Shouldn't Be Surprised By Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 30% Share Price Plunge - Simply Wall St

Nov 13, 2024

Nov 13, 2024

Heron Therapeutics Inc (HRTX) Quarterly 10-Q Report - Quartz

Nov 13, 2024

Nov 13, 2024

Investors Don't See Light At End Of Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Tunnel And Push Stock Down 30% - Simply Wall St

Nov 13, 2024

Nov 13, 2024

Earnings call: Heron Therapeutics projects higher Q4 revenue By Investing.com - Investing.com UK

Nov 13, 2024

Nov 13, 2024

Starbucks To $77? Here Are 10 Top Analyst Forecasts For WednesdayStarbucks (NASDAQ:SBUX) - Benzinga

Nov 13, 2024

Nov 12, 2024

Heron Therapeutics Reports Q3 2024 Results and Narrows Guidance - TipRanks

Nov 12, 2024

Nov 12, 2024

Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn

Nov 12, 2024

Nov 12, 2024

Heron Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Heron Therapeutics reports Q3 EPS (3c), consensus (3c) - TipRanks

Nov 12, 2024

Nov 10, 2024

Heron Therapeutics (HRTX) Set to Announce Earnings on Tuesday - Defense World

Nov 10, 2024